Tag: Sanofi
Dax has a mark of 14,000 points in sight
Dusseldorf After three days of profits in a row, skepticism dominates the German stock market. On Wednesday, the Dax increases its losses and is 1.5 percent lower at 13,700 points…
Dax has a mark of 14,000 points in sight
Dusseldorf After three days of profits in a row, skepticism dominates the German stock market. On Wednesday, the Dax increases its losses and is one percent lower at 13,777 points…
Dax has a mark of 14,000 points in sight
Dusseldorf After three days of profits in a row, restraint is dominating the German stock market. On Wednesday morning, the Dax fell by 0.4 percent to 13,850 points and moved…
Dax has a mark of 14,000 points in sight
Dusseldorf The German stock market is getting closer and closer to the 14,000 point mark. On Wednesday morning, the leading German index was initially at the level of the previous…
These ten stocks are crisis-proof
Shares Which titles let you sit back and relax? Insecure at best, desperate at worst – this is how the mood among investors is: Because of high inflation rates and…
These ten stocks are crisis-proof
Shares Which titles let you sit back and relax? Insecure at best, desperate at worst – this is how the mood among investors is: Because of high inflation rates and…
Sanofi, GSK, Boehringer Ingelheim: Investors fear wave of lawsuits
Stomach medication Zantac Several pharmaceutical companies are threatened with lawsuits in the USA because of possible carcinogenic ingredients. (Photo: Reuters) Frankfurt A stomach medicine that has been banned from the…
Why monkeypox is an underestimated threat
Monkeypox, a febrile and smallpox-like disease, is currently spreading around the world. The USA has now declared a national health emergency because of the “monkey pox” (abbreviated to MPX). Berlin…
Big Pharma is boosting the blockbuster business with spin-offs
Frankfurt The pharmaceutical industry is in the middle of a profound structural change. The leading companies in the industry are increasingly specializing in drug production. And part with fringe activities…
Eli Lilly brings new injection against diseases of affluence
Research at Eli Lilly The new diabetes drug Mounjaro is said to bring in billions in sales. (Photo: Eli Lilly) Berlin The diabetes drug Mounjaro is considered one of the…
Eli Lilly brings new injection against diseases of affluence
Research at Eli Lilly The new diabetes drug Mounjaro is said to bring in billions in sales. (Photo: Eli Lilly) Berlin The diabetes drug Mounjaro is considered one of the…
Eli Lilly brings new injection against diseases of affluence
Research at Eli Lilly The new diabetes drug Mounjaro is said to bring in billions in sales. (Photo: Eli Lilly) Berlin The diabetes drug Mounjaro is considered one of the…
Bayer brings cell therapy research to Berlin
Bayer in Berlin In the future, the pharmaceutical company also wants to conduct research on novel cell therapies at the Innovation Campus in Berlin. (Photo: dpa) Frankfurt Bayer is building…
How Sanofi wants to become the leader in immunology
Sanofi factory The group invests in Frankfurt. (Photo: Sanofi) Frankfurt The pharmaceutical group Sanofi sees itself on a sustainable growth course and is setting new goals. “We will be the…
How Sanofi wants to become the leader in immunology
Sanofi The French pharmaceutical company has changed a lot under the new CEO Paul Hudson and therefore introduced a new logo at the beginning of this year. (Photo: Reuters) Frankfurt…
Glaxo-Smithkline buys Affinivax for up to $3.3 billion
Covid-19 vaccine The British pharmaceutical giant Glaxo-Smithkline relies on several partners for the corona vaccination. (Photo: Reuters) Frankfurt With the takeover of the US biotech company Affinivax for up to…
These biotech companies are supposed to curb infections
Institute for Microbiology of the German Armed Forces in Munich Drugs and vaccines against monkeypox are now well researched. (Photo: dpa) Frankfurt With the series of monkeypox infections, a new…
Dividends on investments in stock exchange groups
Investment with dividends Dividends should not draw from the substance of the company. (Illustration: Stephan Schmitz) Dusseldorf When prices are volatile, investors do well with companies that often raise their…
Eli Lilly is the new star of the pharmaceutical industry
Frankfurt In the past two years, the headlines in the pharmaceutical industry have been dominated by the American industry leader Pfizer with its Covid vaccine Comirnaty – developed together with…
Evotec seals billion-euro deal with BMS for protein destroyers
Frankfurt With a new deal worth billions, the German biotech company Evotec is expanding its existing alliance with the US pharmaceutical giant Bristol-Myers Squibb (BMS) in the field of “protein…